Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH prophylaxis after knee arthroscopy or lower-leg cast immobilization
NL-OMON41615Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of nadroparin in Phlebothrombosis, deep vein thrombosis (DVT) and pulmonary embolism (PE) (4 arms), sponsored by Leiden University Medical Center. Primary endpoints: Primary efficacy outcome and Primary safety outcome. Started Mar 2012; status: recruiting.
02
Drugs
nadroparin
03
Conditions
Phlebothrombosisdeep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NL-OMON41615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41615.